Valuation : West Pharmaceutical Services, Inc.

Market Cap 24.01B 20.67B 19.41B 17.72B 33.28B 2,284B 33.52B 230B 89.48B 1,158B 90.13B 88.18B 3,835B P/E 2026 *
39.8x
P/E 2027 * 34.6x
Enterprise Value 23.5B 20.24B 19B 17.34B 32.58B 2,236B 32.82B 225B 87.6B 1,134B 88.25B 86.33B 3,755B EV / Sales 2026 *
6.96x
EV / Sales 2027 * 6.4x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.29%
1 day+1.08%
1 week-3.46%
1 month+0.04%
3 months+5.67%
6 months+34.12%
Current year+23.98%
1 week 335.51
Extreme 335.51
353.12
1 month 335.51
Extreme 335.51
360.28
Current year 223.83
Extreme 223.83
386
1 year 223.83
Extreme 223.83
386
3 years 187.43
Extreme 187.43
413.7
5 years 187.43
Extreme 187.43
475.35
10 years 70.17
Extreme 70.17
475.35
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Exercice

Chief Financial Officer

17,408 0.0247%
6/30/26 Other

Director

46 0.0001%
5/12/26 Exercice

Executive/Senior Manager

1,759 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-3.46%+38.13%-16.17% 23.75B
-1.88%-5.41%-16.81%+7.25% 195B
-0.64%-2.42%-2.33%+11.23% 117B
+0.49%-0.05%+10.97%+83.88% 61.45B
-0.74%-1.38%-2.52%-32.69% 51.62B
+1.18%-0.06%+29.15%+54.01% 51.03B
+0.26%-.--%+22.56%-9.82% 34.27B
-0.71%+0.95% - - 30.95B
+1.23%-1.91%-5.11%+15.39% 23.41B
-0.49%-2.20%-5.07%+1.33% 22.79B
Average -0.03%-1.38%+7.66%+12.71% 61.07B
Weighted average by Cap. -0.59%-1.94%-0.12%+14.86%

Financials

2026 *2027 *
Net sales 3.37B 2.91B 2.73B 2.49B 4.68B 321B 4.71B 32.33B 12.58B 163B 12.67B 12.4B 539B 3.59B 3.09B 2.9B 2.65B 4.97B 341B 5.01B 34.36B 13.37B 173B 13.47B 13.18B 573B
Net income 615M 529M 497M 454M 852M 58.47B 858M 5.89B 2.29B 29.65B 2.31B 2.26B 98.18B 701M 604M 567M 517M 972M 66.72B 979M 6.72B 2.61B 33.83B 2.63B 2.58B 112B
Net Debt -503M -433M -407M -371M -698M -47.89B -703M -4.82B -1.88B -24.28B -1.89B -1.85B -80.4B -1.04B -895M -840M -767M -1.44B -98.87B -1.45B -9.95B -3.87B -50.14B -3.9B -3.82B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Date Price Change Volume
26-08-31 US$341.11 +1.08% 615,599
26-08-28 US$337.47 -2.49% 496,405
26-08-27 US$346.09 -1.09% 365,990
26-08-26 US$349.92 +0.41% 440,221
26-08-25 US$348.48 -1.37% 383,760
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
341.11USD
Average target price
404.73USD
Spread / Average Target
+18.65%

Quarterly revenue - Rate of surprise